Related Experiment Video
Updated: Jan 17, 2026
06:55
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.1K
Demystifying Clone-Censor-Weighting to Studying Treatment Initiation Windows: An Example Using Publicly Available
Michael Webster-Clark1,2,3, Yi Li4, Sophie Dell'Aniello5
1Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Pharmacoepidemiology and Drug Safety
|September 21, 2025
Summary
Clone-censor-weighting (CCW) effectively compares drug initiation windows for myocardial infarction patients. This method helps analyze complex treatment comparisons without bias, showing varied outcomes based on timing.
Area of Science:
- Epidemiology
- Biostatistics
- Pharmacovigilance
Background:
- Clone-censor-weighting (CCW) offers a method to compare treatment regimens with indistinguishable starting times.
- Traditional methods often rely on landmarks or create immortal time, which CCW avoids.
- CCW can handle complex causal contrasts in treatment initiation windows.
Purpose of the Study:
- To provide a tutorial on using CCW for comparing treatment initiation windows.
- To illustrate the causal contrasts inherent in comparing different initiation timeframes.
- To demonstrate CCW application in a real-world health data scenario.
Main Methods:
- Utilized Medicare synthetic public data for patients with myocardial infarction.
- Defined three initiation regimens: within 30 days, within 90 days, and between 30-90 days.
- Employed inverse probability of censoring weights (IPCW) to address informative censoring and Kaplan-Meier methods for outcome risk calculation.
Main Results:
- Identified 1589 eligible myocardial infarction patients.
- 15% initiated treatment within 30 days, and 26% initiated between 30-90 days.
- After IPCW, 180-day risks were 40.2% (30-day regimen), 35.7% (90-day regimen), and 35.2% (30-to-90-day regimen).
Conclusions:
- CCW is a valuable tool for contrasting treatment initiation windows, despite implementation complexity.
- Estimated effects can differ significantly based on population-specific treatment initiation patterns.
- The study highlights CCW's utility in analyzing time-dependent treatment effects.
Keywords:
clone‐censor‐weightingselection biastarget trial emulationtreatment timingtreatment windowsMore Related Videos
Related Concept Videos
01:09Censoring Survival Data
529
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
529
01:52Regression Toward the Mean
6.9K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.9K
01:20Comparing the Survival Analysis of Two or More Groups
561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
01:24Kaplan-Meier Approach
577
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
577
01:13Bioequivalence studies: Biowaivers
229
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
229